E-LIB Suche - Ergebnisse für: Lasseter, Kenneth C

1

Effect of Mild and Moderate Hepatic Impairment (Defined by ..:

Zahir, Hamim ; Greenberg, Jonathan ; Hsu, Ching...
The Journal of Clinical Pharmacology. 62 (2022) 8 - p. 992-1005 , 2022

Link: https://doi.org/10.1002/..

2

Pharmacokinetics and Safety of the Novel Selective Progeste..:

Schultze‐Mosgau, Marcus‐Hillert ; Lasseter, Kenneth C. ; Marbury, Thomas..
The Journal of Clinical Pharmacology. 60 (2020) 8 - p. 1030-1038 , 2020

Link: https://doi.org/10.1002/..

3

A Microdose Cocktail to Evaluate Drug Interactions in Patie..:

Tatosian, Daniel A. ; Yee, Ka Lai ; Zhang, Zufei...
Clinical Pharmacology & Therapeutics. 109 (2020) 2 - p. 403-415 , 2020

Link: https://doi.org/10.1002/..

4

Pharmacokinetics of sugammadex in subjects with moderate an..:

Min, K. Chris ; Lasseter, Kenneth C. ; Marbury, Thomas C....
Int. Journal of Clinical Pharmacology and Therapeutics. , 2017

Link: https://doi.org/10.5414/..

5

Pharmacokinetics, Safety, and Tolerability of Single-Dose E..:

Marshall, William L. ; Feng, Hwa-Ping ; Wenning, Larissa...
European Journal of Drug Metabolism and Pharmacokinetics. 43 (2017) 3 - p. 321-329 , 2017

Link: https://doi.org/10.1007/..

6

The Influence of Hepatic and Renal Impairment on the Pharma..:

Kusawake, Tomohiro ; Kowalski, Donna ; Takada, Akitsugu...
Advances in Therapy. 34 (2017) 12 - p. 2612-2624 , 2017

Link: https://doi.org/10.1007/..

7

Moderate Hepatic Impairment Does Not Affect Doravirine Phar..:

Khalilieh, Sauzanne ; Yee, Ka Lai ; Liu, Rachael...
The Journal of Clinical Pharmacology. 57 (2016) 6 - p. 777-783 , 2016

Link: https://doi.org/10.1002/..

8

Pharmacokinetic Interactions Between Isavuconazole and the ..:

Yamazaki, Takao ; Desai, Amit ; Goldwater, Ronald...
Clinical Pharmacology in Drug Development. 6 (2016) 1 - p. 66-75 , 2016

Link: https://doi.org/10.1002/..

9

Influence of renal and hepatic impairment on the pharmacoki..:

Lauring, Brett ; Li, Xiujiang (Susie) ; Liu, Yang...
The Journal of Clinical Pharmacology. 54 (2014) 11 - p. 1247-1255 , 2014

Link: https://doi.org/10.1002/..

10

The effect of rifampin on the pharmacokinetics of sirolimus..:

Tortorici, Michael A. ; Matschke, Kyle ; Korth‐Bradley, Joan M...
Clinical Pharmacology in Drug Development. 3 (2013) 1 - p. 51-56 , 2013

Link: https://doi.org/10.1002/..

11

Odanacatib, a selective cathepsin K inhibitor to treat oste..:

Stoch, S. Aubrey ; Zajic, Stefan ; Stone, Julie A....
British Journal of Clinical Pharmacology. 75 (2013) 5 - p. 1240-1254 , 2013

Link: https://doi.org/10.1111/..

12

The Effect of Moderate Hepatic Impairment on the Pharmacoki..:

Zhang, Wenhui ; Krauwinkel, Walter J. J. ; Keirns, James...
Clinical Drug Investigation. 33 (2013) 7 - p. 489-496 , 2013

Link: https://doi.org/10.1007/..

13

Evaluation of the Single-dose Pharmacokinetics of Bilastine..:

Lasseter, Kenneth C. ; Sologuren, Ander ; La Noce, Anna.
Clinical Drug Investigation. 33 (2013) 9 - p. 665-673 , 2013

Link: https://doi.org/10.1007/..

14

Segmental Bioimpedance for Measuring Amlodipine-Induced Ped..:

Schoeller, Dale A. ; Alon, Achilles ; Manekas, Demetrios...
Clinical Therapeutics. 34 (2012) 3 - p. 580-592 , 2012

Link: https://doi.org/10.1016/..

15

Pharmacokinetics of Oral Tonapofylline and Its Acyl‐Glucuro..:

Li, Zhaoyang ; Gan, Liang‐Shang ; Marbury, Thomas...
The Journal of Clinical Pharmacology. 52 (2012) 4 - p. 543-551 , 2012

Link: https://doi.org/10.1177/..